DUX4L6

Model summary

A nuclear transcriptional regulator that uses tandem homeodomain DNA-binding modules to recognize cis-regulatory elements and activate RNA polymerase II–dependent transcription. By assembling with transcriptional coactivators and basal machinery, it stimulates gene programs that restrain proliferation and cell-cycle entry and can engage apoptotic pathways. Its activity centers in the nucleoplasm with transient excursions near nuclear and cytoplasmic interfaces that support assembly, trafficking, and regulation of transcriptional complexes.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   Two homeobox signatures dominate the N-terminal half of the protein: IPR001356 (Homeodomain, residues 17–81) and a second homeodomain call IPR001356 (Homeodomain, residues 92–156). These are embedded within broader homeodomain-like scaffolds: IPR009057 (Homeodomain-like superfamily, residues 14–86) at the N-terminal region and IPR009057 (Homeodomain-like superfamily, residues 87–154) overlapping the second homeodomain. This tandem arrangement of homeodomains is reinforced by IPR051306 (Homeobox domain-containing regulator family, residues 17–380), which extends far beyond the DNA-binding cores and signals a transcriptional regulator scaffold rather than an enzyme. A conserved DNA-recognition element, IPR000047 (Helix-turn-helix motif, residues 123–148), sits within the second homeodomain and provides the canonical recognition helix that inserts into the major groove of DNA. The ordered layout—tandem homeodomains bracketed by homeodomain-like superfamily envelopes and capped by an HTH recognition module—creates a high-specificity, high-affinity DNA-binding platform that targets cis-regulatory elements and recruits transcriptional machinery.

2. 02

   This architecture causes sequence-specific DNA binding and transcriptional activation.

   The paired homeodomains and HTH motif directly support GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding and GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific. The extended family region (IPR051306) and the absence of catalytic motifs imply that transcriptional output is tuned through protein–protein interfaces, consistent with GO:0005515 protein binding. Together, these features define a transcription factor that binds enhancers and promoters and stimulates RNA polymerase II-dependent transcription.

3. 03

   From this molecular function, the biological processes follow.

   By activating Pol II transcription (GO:0045944 positive regulation of transcription by RNA polymerase II), the factor can drive programs that restrain proliferation and cell cycle entry, explaining GO:0008285 negative regulation of cell population proliferation and GO:0070317 negative regulation of G0 to G1 transition. Such repression can be coupled to cell-fate pathways; transcriptional control of pro-death modules and checkpoint pathways rationalizes GO:0006915 apoptotic process. The tandem homeodomains often integrate developmental and stress-responsive cues; here, their regulatory reach provides a mechanistic basis for coupling transcriptional activation to growth suppression and apoptosis.

4. 04

   Cellular localization is dictated by the DNA-centric mechanism.

   The homeodomain architecture and transcriptional role place the protein in the nucleus, specifically the GO:0005654 nucleoplasm where chromatin-bound transcription occurs. Dynamic shuttling and assembly of transcriptional complexes can transiently expose the factor to the GO:0005829 cytosol and GO:0031965 nuclear membrane during nuclear import/export and periphery-associated regulation. Association with ribonucleoprotein assembly and surveillance pathways can account for detection in the GO:0005730 nucleolus, and trafficking or quality-control routes may explain occasional residence near the GO:0005794 Golgi apparatus. The dominant steady-state, however, is nuclear.

5. 05

   Mechanistically, the tandem homeodomains bind specific cis-regulatory sequences and recruit coactivators and the basal transcriptional apparatus to stimulate Pol II initiation and elongation.

   I hypothesize that the protein assembles with Mediator and TFIID at enhancer–promoter hubs, engages histone acetyltransferases to open chromatin, and interfaces with cell-cycle regulators to enforce G0/G1 restraint. Likely partners include Mediator subunits and coactivators (e.g., EP300/CBP), core Pol II factors (e.g., TFIID/TAFs), SWI/SNF chromatin remodelers, and cell-cycle gatekeepers such as RB1/E2F complexes. Through these assemblies, the factor activates transcriptional programs that suppress proliferation and can tip the balance toward apoptosis when necessary.